Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer

Bibliographic Details
Main Authors: Chiorean, E Gabriela, Von Hoff, Daniel D, Tabernero, Josep, El-Maraghi, Robert, Ma, Wen Wee, Reni, Michele, Harris, Marion, Whorf, Robert, Liu, Helen, Li, Jack Shiansong, Manax, Victoria, Romano, Alfredo, Lu, Brian, Goldstein, David
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947701/
id pubmed-4947701
recordtype oai_dc
spelling pubmed-49477012016-07-27 Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer Chiorean, E Gabriela Von Hoff, Daniel D Tabernero, Josep El-Maraghi, Robert Ma, Wen Wee Reni, Michele Harris, Marion Whorf, Robert Liu, Helen Li, Jack Shiansong Manax, Victoria Romano, Alfredo Lu, Brian Goldstein, David Clinical Study Nature Publishing Group 2016-07-12 2016-06-28 /pmc/articles/PMC4947701/ /pubmed/27351217 http://dx.doi.org/10.1038/bjc.2016.185 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by/4.0/ This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Chiorean, E Gabriela
Von Hoff, Daniel D
Tabernero, Josep
El-Maraghi, Robert
Ma, Wen Wee
Reni, Michele
Harris, Marion
Whorf, Robert
Liu, Helen
Li, Jack Shiansong
Manax, Victoria
Romano, Alfredo
Lu, Brian
Goldstein, David
spellingShingle Chiorean, E Gabriela
Von Hoff, Daniel D
Tabernero, Josep
El-Maraghi, Robert
Ma, Wen Wee
Reni, Michele
Harris, Marion
Whorf, Robert
Liu, Helen
Li, Jack Shiansong
Manax, Victoria
Romano, Alfredo
Lu, Brian
Goldstein, David
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
author_facet Chiorean, E Gabriela
Von Hoff, Daniel D
Tabernero, Josep
El-Maraghi, Robert
Ma, Wen Wee
Reni, Michele
Harris, Marion
Whorf, Robert
Liu, Helen
Li, Jack Shiansong
Manax, Victoria
Romano, Alfredo
Lu, Brian
Goldstein, David
author_sort Chiorean, E Gabriela
title Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
title_short Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
title_full Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
title_fullStr Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
title_full_unstemmed Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
title_sort second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
description
publisher Nature Publishing Group
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947701/
_version_ 1613610528433766400

Similar Items